Richard S Levy
CIK 1454983 · EVP, Chief Drug Dev Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.96M
Companies
6
Total Filings
97
Lifetime Open-Market Net
-$69.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KNSA | Director | 21,956 | $51.89 | $1.14M | $0 | 14 | 2026-06-02 |
| MDGL | Director | 26,576 | $480.77 | $12.78M | -$19.89M | 22 | 2026-05-22 |
| KOD | Director | 250 | $34.06 | $8.5K | $44.3K | 9 | 2025-07-02 |
| TARA | Director | 51,000 | $3.90 | $198.9K | $127.6K | 9 | 2025-06-13 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Director | — | $33.99 | — | $0 | 2 | 2021-06-04 |
| INCY | EVP, Chief Drug Dev Officer | 16,926 | $108.53 | $1.84M | -$49.87M | 40 | 2016-01-08 |
Recent Filings · Page 3 of 10
97 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-07 | KNSA | Mixed | +4,373 | $0 | EDGAR |
| 2024-05-07 | KNSA | Mixed | +747 | $0 | EDGAR |
| 2024-04-03 | MDGL | Mixed | — | -$2.13M | EDGAR |
| 2023-11-07 | KNSA | Mixed | +2,777 | $0 | EDGAR |
| 2023-07-03 | KNSA | Exer (M) | +5,000 | $0 | EDGAR |
| 2023-07-03 | KOD | Grant (A) | — | $0 | EDGAR |
| 2023-06-20 | MDGL | Grant (A) | +1,198 | $0 | EDGAR |
| 2023-06-08 | KNSA | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | TARA | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | MDGL | Mixed | — | -$4.28M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.